Literature DB >> 21950817

Barrett's esophagus: treatments of adenocarcinomas I.

Srinadh Komanduri1, Pierre H Deprez, Ajlan Atasoy, Günther Hofmann, Peter Pokieser, Ahmed Ba-Ssalamah, Jean-Marie Collard, Bas P Wijnhoven, Roy J J Verhage, Björn Brücher, Christoph Schuhmacher, Marcus Feith, Hubert Stein.   

Abstract

The following on the treatments of adenocarcinomas in Barrett's esophagus contains commentaries on endo mucosal resection; choice between other ablative therapies; the remaining genetic abnormalities following stepwise endoscopic mucosal resection and possible recurrences; the Fotelo-Fotesi PDT; the CT TNM classification of early stages of Barrett's carcinoma; the indications of lymphadenectomy in intramucosal cancer; the differences in lymph node yield in transthoracic versus transhiatal dissection; video-assisted lymphadenectomy; and the importance of the length of proximal esophageal resectipon; and indications of sentinel node dissection.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2011        PMID: 21950817     DOI: 10.1111/j.1749-6632.2011.06055.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

Review 1.  [Update on Barrett esophagus and Barrett carcinoma].

Authors:  M Werner; S Laßmann
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 2.  Undervalued criteria in the evaluation of multimodal trials for upper GI cancers.

Authors:  Björn L D M Brücher; Masaki Kitajima; Jörg Rüdiger Siewert
Journal:  Cancer Invest       Date:  2014-09-24       Impact factor: 2.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.